Cancer Biological Therapy Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023
Prominent market Research was established in 2018 with an energetic team of competent professional to take on the challenges of market analysis in the capacity of market insight needs. We deliver the benefits of this expertise to you through our market re
(EMAILWIRE.COM, June 19, 2018 ) Woodridge, USA Jun 2018(News) - The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.
The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.
On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, inter ferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.
On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.
Key Players
The leading market players in the global cancer biological therapy market include
Merck Inc., F. Hoffmann-La Roche Ltd,
Novartis AG,
Amgen Inc., Bristol-Myers Squibb,
Celgene, ELI Lilly and Company,
EnGeneIC,
Pfizer
Key Findings
• North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
• Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
• Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016
Get Free Sample Report: https://www.prominentmarketresearch.com/sample-report/210
Table of content:
1 Report Prologue
2 Market Definition
3 Research Methodology
4 Market Dynamics
Ask For Report Discount: https://www.prominentmarketresearch.com/discount-report/210
5 Market Factor Analysis
6 Global Cancer Biological Therapy Market, by phases
6 Global Cancer Biological Therapy Market, by phases
Buy Report: https://www.prominentmarketresearch.com/checkout/210
8 Global Cancer Biological Therapy Market, by End Users
9 Global Cancer Biological Therapy Market, by Region
10 Competitive Landscape
Contact Us:
Robin,
Sales Manager,
Tel- +1-815-957-4373
Email- sales@prominentmarketresearch.com
The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.
On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, inter ferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.
On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.
Key Players
The leading market players in the global cancer biological therapy market include
Merck Inc., F. Hoffmann-La Roche Ltd,
Novartis AG,
Amgen Inc., Bristol-Myers Squibb,
Celgene, ELI Lilly and Company,
EnGeneIC,
Pfizer
Key Findings
• North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
• Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
• Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016
Get Free Sample Report: https://www.prominentmarketresearch.com/sample-report/210
Table of content:
1 Report Prologue
2 Market Definition
3 Research Methodology
4 Market Dynamics
Ask For Report Discount: https://www.prominentmarketresearch.com/discount-report/210
5 Market Factor Analysis
6 Global Cancer Biological Therapy Market, by phases
6 Global Cancer Biological Therapy Market, by phases
Buy Report: https://www.prominentmarketresearch.com/checkout/210
8 Global Cancer Biological Therapy Market, by End Users
9 Global Cancer Biological Therapy Market, by Region
10 Competitive Landscape
Contact Us:
Robin,
Sales Manager,
Tel- +1-815-957-4373
Email- sales@prominentmarketresearch.com
Contact Information:
Prominent Market Research
Robin
Tel: +1-815-957-4373
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Prominent Market Research
Robin
Tel: +1-815-957-4373
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results